Annual EBIT
$10.33 B
+$3.19 B+44.65%
31 December 2023
Summary:
Eli Lilly and Company annual earnings before interest & taxes is currently $10.33 billion, with the most recent change of +$3.19 billion (+44.65%) on 31 December 2023. During the last 3 years, it has risen by +$2.74 billion (+36.05%). LLY annual EBIT is now at all-time high.LLY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$1.78 B
-$1.92 B-51.87%
30 September 2024
Summary:
Eli Lilly and Company quarterly earnings before interest & taxes is currently $1.78 billion, with the most recent change of -$1.92 billion (-51.87%) on 30 September 2024. Over the past year, it has increased by +$1.23 billion (+222.78%). LLY quarterly EBIT is now -51.87% below its all-time high of $3.70 billion, reached on 30 June 2024.LLY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$10.84 B
+$1.23 B+12.78%
30 September 2024
Summary:
Eli Lilly and Company TTM earnings before interest & taxes is currently $10.84 billion, with the most recent change of +$1.23 billion (+12.78%) on 30 September 2024. Over the past year, it has increased by +$4.27 billion (+64.96%). LLY TTM EBIT is now at all-time high.LLY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.6% | +222.8% | +65.0% |
| 3 y3 years | +36.0% | +34.0% | +52.0% |
| 5 y5 years | +163.2% | +17.7% | +121.5% |
LLY EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +59.0% | -51.9% | +222.8% | at high | +67.0% |
| 5 y | 5 years | at high | +163.2% | -51.9% | +222.8% | at high | +121.5% |
| alltime | all time | at high | +1056.7% | -51.9% | +154.7% | at high | +1104.8% |
Eli Lilly And Company EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.78 B(-51.9%) | $10.84 B(+12.8%) |
| June 2024 | - | $3.70 B(+36.3%) | $9.62 B(+18.4%) |
| Mar 2024 | - | $2.72 B(+2.6%) | $8.12 B(+15.4%) |
| Dec 2023 | $10.33 B(+44.7%) | $2.65 B(+379.7%) | $7.04 B(+7.1%) |
| Sept 2023 | - | $551.80 M(-75.0%) | $6.57 B(-14.3%) |
| June 2023 | - | $2.21 B(+35.3%) | $7.67 B(+15.6%) |
| Mar 2023 | - | $1.63 B(-25.1%) | $6.63 B(-7.1%) |
| Dec 2022 | $7.14 B(+9.9%) | $2.18 B(+32.4%) | $7.14 B(+3.8%) |
| Sept 2022 | - | $1.65 B(+40.5%) | $6.88 B(+4.8%) |
| June 2022 | - | $1.17 B(-45.2%) | $6.56 B(-7.2%) |
| Mar 2022 | - | $2.14 B(+11.3%) | $7.07 B(+8.8%) |
| Dec 2021 | $6.50 B(-14.4%) | $1.92 B(+44.6%) | $6.50 B(-8.9%) |
| Sept 2021 | - | $1.33 B(-20.9%) | $7.13 B(-2.7%) |
| June 2021 | - | $1.68 B(+7.5%) | $7.33 B(-0.7%) |
| Mar 2021 | - | $1.56 B(-38.9%) | $7.38 B(-2.7%) |
| Dec 2020 | $7.59 B(+33.9%) | $2.56 B(+67.6%) | $7.59 B(+11.8%) |
| Sept 2020 | - | $1.53 B(-11.8%) | $6.79 B(+0.2%) |
| June 2020 | - | $1.73 B(-2.3%) | $6.78 B(+2.3%) |
| Mar 2020 | - | $1.77 B(+0.8%) | $6.62 B(+16.8%) |
| Dec 2019 | $5.67 B(+44.5%) | $1.76 B(+16.2%) | $5.67 B(+15.7%) |
| Sept 2019 | - | $1.51 B(-4.0%) | $4.90 B(+2.3%) |
| June 2019 | - | $1.58 B(+92.9%) | $4.79 B(+44.4%) |
| Mar 2019 | - | $817.60 M(-17.3%) | $3.31 B(-15.5%) |
| Dec 2018 | $3.92 B(+55.1%) | $988.80 M(-29.5%) | $3.92 B(+15.8%) |
| Sept 2018 | - | $1.40 B(+1235.1%) | $3.39 B(+28.4%) |
| June 2018 | - | $105.00 M(-92.6%) | $2.64 B(-31.4%) |
| Mar 2018 | - | $1.43 B(+214.0%) | $3.85 B(+52.1%) |
| Dec 2017 | $2.53 B(-28.9%) | $454.40 M(-30.5%) | $2.53 B(-16.2%) |
| Sept 2017 | - | $653.50 M(-50.3%) | $3.02 B(-10.8%) |
| June 2017 | - | $1.31 B(+1119.0%) | $3.38 B(+10.7%) |
| Mar 2017 | - | $107.80 M(-88.6%) | $3.06 B(-14.1%) |
| Dec 2016 | $3.56 B(+20.6%) | $943.40 M(-7.3%) | $3.56 B(+14.6%) |
| Sept 2016 | - | $1.02 B(+3.1%) | $3.10 B(-2.2%) |
| June 2016 | - | $987.70 M(+61.9%) | $3.17 B(+9.3%) |
| Mar 2016 | - | $610.20 M(+24.8%) | $2.90 B(-1.6%) |
| Dec 2015 | $2.95 B(-6.3%) | $488.80 M(-55.0%) | $2.95 B(-2.1%) |
| Sept 2015 | - | $1.09 B(+51.7%) | $3.01 B(+15.0%) |
| June 2015 | - | $716.50 M(+8.8%) | $2.62 B(-9.0%) |
| Mar 2015 | - | $658.80 M(+19.6%) | $2.88 B(-8.6%) |
| Dec 2014 | $3.15 B(-47.9%) | $551.00 M(-20.6%) | $3.15 B(-11.2%) |
| Sept 2014 | - | $693.60 M(-28.9%) | $3.55 B(-19.5%) |
| June 2014 | - | $975.90 M(+5.1%) | $4.41 B(-11.6%) |
| Mar 2014 | - | $928.60 M(-2.2%) | $4.99 B(-17.6%) |
| Dec 2013 | $6.05 B(+8.3%) | $949.60 M(-38.9%) | $6.05 B(-1.7%) |
| Sept 2013 | - | $1.55 B(-0.1%) | $6.15 B(-5.6%) |
| June 2013 | - | $1.56 B(-21.9%) | $6.52 B(+5.3%) |
| Mar 2013 | - | $1.99 B(+88.8%) | $6.20 B(+10.9%) |
| Dec 2012 | $5.59 B(+0.9%) | $1.05 B(-45.1%) | $5.59 B(-0.7%) |
| Sept 2012 | - | $1.92 B(+56.4%) | $5.62 B(+7.1%) |
| June 2012 | - | $1.23 B(-11.0%) | $5.25 B(-6.2%) |
| Mar 2012 | - | $1.38 B(+26.4%) | $5.60 B(+1.1%) |
| Dec 2011 | $5.54 B(-17.5%) | $1.09 B(-29.4%) | $5.54 B(-6.1%) |
| Sept 2011 | - | $1.55 B(-1.8%) | $5.90 B(-2.8%) |
| June 2011 | - | $1.58 B(+19.5%) | $6.07 B(-3.3%) |
| Mar 2011 | - | $1.32 B(-9.2%) | $6.28 B(-6.5%) |
| Dec 2010 | $6.71 B(+19.4%) | $1.45 B(-15.5%) | $6.71 B(+4.1%) |
| Sept 2010 | - | $1.72 B(-3.7%) | $6.45 B(+10.1%) |
| June 2010 | - | $1.78 B(+1.6%) | $5.86 B(+4.5%) |
| Mar 2010 | - | $1.76 B(+47.8%) | $5.60 B(-0.3%) |
| Dec 2009 | $5.62 B(-620.6%) | $1.19 B(+5.2%) | $5.62 B(+377.7%) |
| Sept 2009 | - | $1.13 B(-26.3%) | $1.18 B(-932.4%) |
| June 2009 | - | $1.53 B(-13.5%) | -$141.30 M(-66.7%) |
| Mar 2009 | - | $1.77 B(-154.4%) | -$424.40 M(-60.7%) |
| Dec 2008 | -$1.08 B(-122.5%) | -$3.26 B(+1624.3%) | -$1.08 B(-131.9%) |
| Sept 2008 | - | -$188.80 M(-115.1%) | $3.38 B(-29.2%) |
| June 2008 | - | $1.25 B(+11.9%) | $4.78 B(-0.1%) |
| Mar 2008 | - | $1.12 B(-7.6%) | $4.79 B(-0.3%) |
| Dec 2007 | $4.80 B(+16.4%) | $1.21 B(-0.2%) | $4.80 B(+3.2%) |
| Sept 2007 | - | $1.21 B(-3.4%) | $4.65 B(+3.6%) |
| June 2007 | - | $1.25 B(+10.6%) | $4.49 B(+6.1%) |
| Mar 2007 | - | $1.13 B(+7.1%) | $4.23 B(+2.6%) |
| Dec 2006 | $4.13 B(+13.1%) | $1.06 B(+0.7%) | $4.13 B(+1.9%) |
| Sept 2006 | - | $1.05 B(+5.7%) | $4.05 B(+3.0%) |
| June 2006 | - | $993.60 M(-3.0%) | $3.93 B(+2.8%) |
| Mar 2006 | - | $1.02 B(+4.4%) | $3.83 B(+4.9%) |
| Dec 2005 | $3.65 B(-0.3%) | $981.40 M(+5.1%) | $3.65 B(+0.2%) |
| Sept 2005 | - | $933.50 M(+5.1%) | $3.64 B(+2.0%) |
| June 2005 | - | $887.90 M(+5.0%) | $3.57 B(-0.5%) |
| Mar 2005 | - | $845.80 M(-13.2%) | $3.59 B(-1.9%) |
| Dec 2004 | $3.66 B | $974.90 M(+12.9%) | $3.66 B(+2.4%) |
| Sept 2004 | - | $863.60 M(-4.6%) | $3.57 B(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $905.50 M(-1.0%) | $3.64 B(+1.3%) |
| Mar 2004 | - | $914.70 M(+2.8%) | $3.59 B(+2.6%) |
| Dec 2003 | $3.50 B(+5.2%) | $889.80 M(-4.2%) | $3.50 B(-0.1%) |
| Sept 2003 | - | $928.60 M(+8.1%) | $3.50 B(+1.0%) |
| June 2003 | - | $859.40 M(+4.3%) | $3.47 B(+2.1%) |
| Mar 2003 | - | $824.00 M(-7.7%) | $3.40 B(+2.2%) |
| Dec 2002 | $3.33 B(-10.8%) | $892.70 M(-0.2%) | $3.33 B(+3.2%) |
| Sept 2002 | - | $894.50 M(+13.3%) | $3.22 B(+0.0%) |
| June 2002 | - | $789.60 M(+5.2%) | $3.22 B(-7.4%) |
| Mar 2002 | - | $750.90 M(-4.9%) | $3.48 B(-6.7%) |
| Dec 2001 | $3.73 B(+4.8%) | $789.60 M(-11.6%) | $3.73 B(-3.5%) |
| Sept 2001 | - | $893.50 M(-14.7%) | $3.86 B(-3.1%) |
| June 2001 | - | $1.05 B(+4.9%) | $3.99 B(+5.9%) |
| Mar 2001 | - | $999.00 M(+8.2%) | $3.76 B(+5.7%) |
| Dec 2000 | $3.56 B(+5.8%) | $923.10 M(-9.1%) | $3.56 B(-1.3%) |
| Sept 2000 | - | $1.02 B(+23.0%) | $3.61 B(+3.4%) |
| June 2000 | - | $825.60 M(+3.8%) | $3.49 B(+2.5%) |
| Mar 2000 | - | $795.60 M(-17.9%) | $3.40 B(+1.2%) |
| Dec 1999 | $3.36 B(+19.1%) | $969.50 M(+8.0%) | $3.36 B(+7.9%) |
| Sept 1999 | - | $897.70 M(+21.2%) | $3.12 B(+4.8%) |
| June 1999 | - | $740.40 M(-2.1%) | $2.98 B(+4.1%) |
| Mar 1999 | - | $756.10 M(+4.6%) | $2.86 B(+1.2%) |
| Dec 1998 | $2.82 B(+15.8%) | $722.70 M(-4.4%) | $2.82 B(+3.8%) |
| Sept 1998 | - | $756.20 M(+21.5%) | $2.72 B(+4.5%) |
| June 1998 | - | $622.30 M(-14.0%) | $2.60 B(+3.2%) |
| Mar 1998 | - | $723.30 M(+16.8%) | $2.52 B(+3.5%) |
| Dec 1997 | $2.44 B(+19.3%) | $619.40 M(-3.2%) | $2.44 B(+3.5%) |
| Sept 1997 | - | $639.70 M(+18.4%) | $2.36 B(+4.5%) |
| June 1997 | - | $540.50 M(-15.4%) | $2.25 B(+4.6%) |
| Mar 1997 | - | $638.80 M(+19.0%) | $2.15 B(+5.4%) |
| Dec 1996 | $2.04 B(+3.2%) | $537.00 M(-0.0%) | $2.04 B(+4.2%) |
| Sept 1996 | - | $537.20 M(+21.9%) | $1.96 B(+1.5%) |
| June 1996 | - | $440.80 M(-16.7%) | $1.93 B(-0.9%) |
| Mar 1996 | - | $529.30 M(+16.4%) | $1.95 B(-1.6%) |
| Dec 1995 | $1.98 B(+10.4%) | $454.80 M(-10.4%) | $1.98 B(+9.8%) |
| Sept 1995 | - | $507.50 M(+10.7%) | $1.81 B(-0.9%) |
| June 1995 | - | $458.60 M(-18.2%) | $1.82 B(-0.9%) |
| Mar 1995 | - | $560.90 M(+101.4%) | $1.84 B(+2.4%) |
| Dec 1994 | $1.79 B(+175.0%) | $278.50 M(-46.8%) | $1.79 B(+126.9%) |
| Sept 1994 | - | $523.50 M(+10.2%) | $790.90 M(+16.2%) |
| June 1994 | - | $475.10 M(-8.2%) | $680.50 M(+2.8%) |
| Mar 1994 | - | $517.80 M(-171.4%) | $662.10 M(+1.5%) |
| Dec 1993 | $652.60 M(-43.5%) | -$725.50 M(-275.6%) | $652.60 M(-64.2%) |
| Sept 1993 | - | $413.10 M(-9.5%) | $1.82 B(+65.3%) |
| June 1993 | - | $456.70 M(-10.2%) | $1.10 B(+1.8%) |
| Mar 1993 | - | $508.30 M(+14.1%) | $1.08 B(-6.2%) |
| Dec 1992 | $1.16 B(-34.7%) | $445.30 M(-244.9%) | $1.16 B(+1.1%) |
| Sept 1992 | - | -$307.40 M(-170.3%) | $1.14 B(-38.5%) |
| June 1992 | - | $437.50 M(-24.6%) | $1.86 B(+0.4%) |
| Mar 1992 | - | $580.10 M(+33.9%) | $1.85 B(+4.8%) |
| Dec 1991 | $1.77 B(+14.9%) | $433.20 M(+5.9%) | $1.77 B(+2.8%) |
| Sept 1991 | - | $409.00 M(-5.0%) | $1.72 B(+2.5%) |
| June 1991 | - | $430.30 M(-13.2%) | $1.68 B(+4.5%) |
| Mar 1991 | - | $495.80 M(+28.7%) | $1.61 B(+4.3%) |
| Dec 1990 | $1.54 B(+32.2%) | $385.30 M(+5.2%) | $1.54 B(+12.7%) |
| Sept 1990 | - | $366.40 M(+2.5%) | $1.37 B(+9.2%) |
| June 1990 | - | $357.60 M(-16.9%) | $1.25 B(+4.7%) |
| Mar 1990 | - | $430.10 M(+103.5%) | $1.19 B(-40.0%) |
| Dec 1989 | $1.16 B(+11.3%) | $211.30 M(-15.9%) | $1.99 B(-1077.6%) |
| Sept 1989 | - | $251.20 M(-16.5%) | -$203.40 M(-141.9%) |
| June 1989 | - | $301.00 M(-75.4%) | $486.00 M(-59.5%) |
| Mar 1989 | - | $1.23 B(-161.8%) | $1.20 B(+14.6%) |
| Dec 1988 | $1.05 B(+75.9%) | -$1.98 B(-310.6%) | $1.05 B(+78.0%) |
| Sept 1988 | - | $940.60 M(-7.3%) | $588.10 M(-2.8%) |
| June 1988 | - | $1.01 B(-5.4%) | $605.20 M(-0.5%) |
| Mar 1988 | - | $1.07 B(-144.0%) | $608.10 M(+2.2%) |
| Dec 1987 | $595.00 M(-30.8%) | -$2.44 B(-354.7%) | $595.00 M(-48.0%) |
| Sept 1987 | - | $957.70 M(-5.9%) | $1.14 B(+6.9%) |
| June 1987 | - | $1.02 B(-3.9%) | $1.07 B(+14.9%) |
| Mar 1987 | - | $1.06 B(-156.0%) | $931.00 M(+8.2%) |
| Dec 1986 | $860.30 M(+12.5%) | -$1.89 B(-314.0%) | $860.30 M(-19.0%) |
| Sept 1986 | - | $883.40 M(+0.5%) | $1.06 B(+9.9%) |
| June 1986 | - | $879.30 M(-11.0%) | $966.30 M(+14.5%) |
| Mar 1986 | - | $988.30 M(-158.5%) | $843.80 M(+10.4%) |
| Dec 1985 | $764.40 M(+2.7%) | -$1.69 B(-314.4%) | $764.30 M(-11.8%) |
| Sept 1985 | - | $787.90 M(+4.1%) | $866.50 M(+9.5%) |
| June 1985 | - | $756.80 M(-16.7%) | $791.20 M(+4.3%) |
| Mar 1985 | - | $908.80 M(-157.3%) | $758.30 M(+1.9%) |
| Dec 1984 | $744.30 M | -$1.59 B(-322.7%) | $744.30 M(-68.1%) |
| Sept 1984 | - | $712.60 M(-1.6%) | $2.33 B(+44.0%) |
| June 1984 | - | $723.90 M(-19.1%) | $1.62 B(+80.9%) |
| Mar 1984 | - | $894.80 M | $894.80 M |
FAQ
- What is Eli Lilly and Company annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eli Lilly and Company?
- What is Eli Lilly and Company annual EBIT year-on-year change?
- What is Eli Lilly and Company quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly EBIT year-on-year change?
- What is Eli Lilly and Company TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eli Lilly and Company?
- What is Eli Lilly and Company TTM EBIT year-on-year change?
What is Eli Lilly and Company annual earnings before interest & taxes?
The current annual EBIT of LLY is $10.33 B
What is the all time high annual EBIT for Eli Lilly and Company?
Eli Lilly and Company all-time high annual earnings before interest & taxes is $10.33 B
What is Eli Lilly and Company annual EBIT year-on-year change?
Over the past year, LLY annual earnings before interest & taxes has changed by +$3.19 B (+44.65%)
What is Eli Lilly and Company quarterly earnings before interest & taxes?
The current quarterly EBIT of LLY is $1.78 B
What is the all time high quarterly EBIT for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly earnings before interest & taxes is $3.70 B
What is Eli Lilly and Company quarterly EBIT year-on-year change?
Over the past year, LLY quarterly earnings before interest & taxes has changed by +$1.23 B (+222.78%)
What is Eli Lilly and Company TTM earnings before interest & taxes?
The current TTM EBIT of LLY is $10.84 B
What is the all time high TTM EBIT for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM earnings before interest & taxes is $10.84 B
What is Eli Lilly and Company TTM EBIT year-on-year change?
Over the past year, LLY TTM earnings before interest & taxes has changed by +$4.27 B (+64.96%)